How Dentists' Personality Traits Affect Communication and Treatment Outcomes in TMD Patients (NCT07074366) | Clinical Trial Compass
CompletedNot Applicable
How Dentists' Personality Traits Affect Communication and Treatment Outcomes in TMD Patients
Egypt30 participantsStarted 2023-12-01
Plain-language summary
This prospective, longitudinal study investigates the influence of dentists' personality traits on patient-reported outcomes among individuals with temporomandibular disorders (TMDs) undergoing splint therapy. Dentists are assessed using the Big Five Inventory-2 Short Form (BFI-2-S), and patients are randomly assigned to them. Key outcomes measured six months after treatment include patient-centered communication, treatment satisfaction, adherence to splint therapy, and changes in psychological distress using validated scales such as the Patient-Centered Communication Scale (PCCS), a structured satisfaction questionnaire, and the DASS-10. The study explores whether traits such as conscientiousness, agreeableness, extraversion, openness, and emotional stability are associated with better patient outcomes in TMD care. This research aims to enhance patient-centered treatment by integrating personality-informed clinical practice and tailored communication strategies.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Eligibility criteria for dentists included:
* Had at least two years of clinical experience in the management of TMDs.
* Were actively involved in the clinical care of TMD patients at the time of the study.
* Willingness to participate and complete the BFI-2-S personality assessment.
Eligibility criteria for patients included:
Inclusion Criteria:
* Diagnosed with TMDs according to Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) guidelines, specifically disc displacement with reduction.
* Exhibiting symptoms of stress or anxiety, as identified by the baseline DASS-10 screening.
* Prescribed occlusal splint therapy as part of their treatment regimen.
Exclusion Criteria:
* Cognitive impairments.
* Psychiatric conditions other than anxiety or depression.
* Any condition that could impair the patient's ability to provide informed consent or accurately complete self-report questionnaires.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.